Iroko Pharmaceuticals, LLC-Product Pipeline Review-2015

Iroko Pharmaceuticals, LLC-Product Pipeline Review-2015

  • Products Id :- GMDHC07727CDB
  • |
  • Pages: 22
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Iroko Pharmaceuticals, LLC-Product Pipeline Review-2015


Global Markets Direct's, 'Iroko Pharmaceuticals, LLC-Product Pipeline Review-2015', provides an overview of the Iroko Pharmaceuticals, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Iroko Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Iroko Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Iroko Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Iroko Pharmaceuticals, LLC's pipeline products

Reasons To Buy

Evaluate Iroko Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Iroko Pharmaceuticals, LLC in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Iroko Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Iroko Pharmaceuticals, LLC and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Iroko Pharmaceuticals, LLC

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Iroko Pharmaceuticals, LLC and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Iroko Pharmaceuticals, LLC Snapshot 4

Iroko Pharmaceuticals, LLC Overview 4

Key Information 4

Key Facts 4

Iroko Pharmaceuticals, LLC-Research and Development Overview 5

Key Therapeutic Areas 5

Iroko Pharmaceuticals, LLC-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Iroko Pharmaceuticals, LLC-Pipeline Products Glance 9

Iroko Pharmaceuticals, LLC-Clinical Stage Pipeline Products 9

Phase II Products/Combination Treatment Modalities 9

Iroko Pharmaceuticals, LLC-Early Stage Pipeline Products 10

Preclinical Products/Combination Treatment Modalities 10

Iroko Pharmaceuticals, LLC-Drug Profiles 11

naproxen sodium 11

Product Description 11

Mechanism of Action 11

R&D Progress 11

celecoxib 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

ibuprofen 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Iroko Pharmaceuticals, LLC-Pipeline Analysis 15

Iroko Pharmaceuticals, LLC-Pipeline Products by Target 15

Iroko Pharmaceuticals, LLC-Pipeline Products by Route of Administration 16

Iroko Pharmaceuticals, LLC-Pipeline Products by Molecule Type 17

Iroko Pharmaceuticals, LLC-Pipeline Products by Mechanism of Action 18

Iroko Pharmaceuticals, LLC-Dormant Projects 19

Iroko Pharmaceuticals, LLC-Locations And Subsidiaries 20

Head Office 20

Appendix 21

Methodology 21

Coverage 21

Secondary Research 21

Primary Research 21

Expert Panel Validation 21

Contact Us 21

Disclaimer 22

List of Tables

Iroko Pharmaceuticals, LLC, Key Information 4

Iroko Pharmaceuticals, LLC, Key Facts 4

Iroko Pharmaceuticals, LLC-Pipeline by Indication, 2015 6

Iroko Pharmaceuticals, LLC-Pipeline by Stage of Development, 2015 7

Iroko Pharmaceuticals, LLC-Monotherapy Products in Pipeline, 2015 8

Iroko Pharmaceuticals, LLC-Phase II, 2015 9

Iroko Pharmaceuticals, LLC-Preclinical, 2015 10

Iroko Pharmaceuticals, LLC-Pipeline by Target, 2015 15

Iroko Pharmaceuticals, LLC-Pipeline by Route of Administration, 2015 16

Iroko Pharmaceuticals, LLC-Pipeline by Molecule Type, 2015 17

Iroko Pharmaceuticals, LLC-Pipeline Products by Mechanism of Action, 2015 18

Iroko Pharmaceuticals, LLC-Dormant Developmental Projects,2015 19

List of Figures

Iroko Pharmaceuticals, LLC-Pipeline by Top 10 Indication, 2015 6

Iroko Pharmaceuticals, LLC-Pipeline by Stage of Development, 2015 7

Iroko Pharmaceuticals, LLC-Monotherapy Products in Pipeline, 2015 8

Iroko Pharmaceuticals, LLC-Pipeline by Top 10 Target, 2015 15

Iroko Pharmaceuticals, LLC-Pipeline by Top 10 Molecule Type, 2015 17

Iroko Pharmaceuticals, LLC-Pipeline Products by Top 10 Mechanism of Action, 2015 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Iroko Pharmaceuticals, LLC; Iroko Pharmaceuticals, LLC-Key Therapeutics; Iroko Pharmaceuticals, LLC-Pipeline Overview and Promising Molecules; Iroko Pharmaceuticals, LLC-News; Iroko Pharmaceuticals, LLC-Latest Updates; Iroko Pharmaceuticals, LLC-Pipeline; Iroko Pharmaceuticals, LLC-Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 95595
Site License
USD 3000 INR 191190
Corporate User License
USD 4500 INR 286785



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]